OSTX stock news
This page provides real-time market news, earnings updates, and company announcements related to OS Therapies Incorporated (OSTX).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-03 07:13 EST

Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
Finviz2026-02-12 13:06:43

Monday.com (MNDY) PT Lowered to $125 by TD Cowen Following Q2 Results, AI Search Disruption
Finviz2026-02-14 06:27:41
OS Therapies Discloses 2026 Timeline For Lead Drug Regulatory Filings
Finviz2026-02-17 14:03:14

NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer
Finviz2026-02-17 21:09:43

Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
Finviz2026-02-18 12:33:42

Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25
Finviz2026-02-18 13:33:36

Netflix vs. Roku: Which Streaming Stock is the Better Buy-the-Dip Target?
Finviz2026-02-19 00:06:05

What kind of software will be eliminated by AI?
华尔街见闻2026-02-19 03:35:14
Roku and Martin Marietta Materials have been highlighted as Zacks Bull and Bear of the Day
Finviz2026-02-19 10:48:42

Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen
Finviz2026-02-19 21:36:38

Recursion to Participate in Upcoming Investor Conferences
Finviz2026-02-23 12:57:48

LiveOne (Nasdaq: LVO) App Now Available on VIZIO Smart TVs
Finviz2026-02-23 14:30:42

StoneCo Ltd. (STNE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Finviz2026-02-23 16:03:11

Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
Finviz2026-02-23 22:15:05
Circle (CRCL) Q4 2025 Earnings Preview: Can USDC Circulation Doubling Reshape the Growth Narrative?
Bitget2026-02-24 04:37:09

monday.com (MNDY) Retains Strong Analyst Confidence Following Q4 and Full-Year Results
Finviz2026-02-26 00:07:16

BeiGene Q4 Revenue Up 33% Year-on-Year, Achieves Annual Profitability; Brukinsa Posts Record High Single-Quarter Sales of 1.1 Billion | Earnings Report Highlights
华尔街见闻2026-02-26 12:57:15
Must-Track Streaming Stocks in the Evolving Media Landscape
Finviz2026-02-26 18:54:38
BMY's Stock Slumps 0.33% Despite Strong Clinical Data, Trading Volume Ranks 201st
101 finance2026-02-26 23:24:44

ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-27 13:03:11

Inseego Introduces MiFi PRO M4, Redefining the Hotspot Category and Advancing Its Vision for the Managed Wireless Edge
Finviz2026-03-02 10:06:53

RadNet Acquires Gleamer, Making RadNet's DeepHealth the Largest Provider of Radiology Clinical AI Solutions Worldwide
Finviz2026-03-02 10:48:46

AIM ImmunoTech Signs Agreement for Planning of a Proposed Phase 3 Clinical Trial of Ampligen in the Treatment of Late-Stage Pancreatic Cancer
Finviz2026-03-02 14:03:11

Oncolytics Biotech Launches Randomized Colorectal Cancer Study
Finviz2026-03-02 14:06:44

Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
Finviz2026-02-18 12:33:42

Recursion to Report Fourth Quarter and Full Year 2025 Business Updates and Financial Results on February 25
Finviz2026-02-18 13:33:36

Netflix vs. Roku: Which Streaming Stock is the Better Buy-the-Dip Target?
Finviz2026-02-19 00:06:05

What kind of software will be eliminated by AI?
华尔街见闻2026-02-19 03:35:14
Roku and Martin Marietta Materials have been highlighted as Zacks Bull and Bear of the Day
Finviz2026-02-19 10:48:42

Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen
Finviz2026-02-19 21:36:38

Recursion to Participate in Upcoming Investor Conferences
Finviz2026-02-23 12:57:48

LiveOne (Nasdaq: LVO) App Now Available on VIZIO Smart TVs
Finviz2026-02-23 14:30:42

StoneCo Ltd. (STNE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Finviz2026-02-23 16:03:11

Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
Finviz2026-02-23 22:15:05
Circle (CRCL) Q4 2025 Earnings Preview: Can USDC Circulation Doubling Reshape the Growth Narrative?
Bitget2026-02-24 04:37:09

monday.com (MNDY) Retains Strong Analyst Confidence Following Q4 and Full-Year Results
Finviz2026-02-26 00:07:16

BeiGene Q4 Revenue Up 33% Year-on-Year, Achieves Annual Profitability; Brukinsa Posts Record High Single-Quarter Sales of 1.1 Billion | Earnings Report Highlights
华尔街见闻2026-02-26 12:57:15
Must-Track Streaming Stocks in the Evolving Media Landscape
Finviz2026-02-26 18:54:38
BMY's Stock Slumps 0.33% Despite Strong Clinical Data, Trading Volume Ranks 201st
101 finance2026-02-26 23:24:44

ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-27 13:03:11

Inseego Introduces MiFi PRO M4, Redefining the Hotspot Category and Advancing Its Vision for the Managed Wireless Edge
Finviz2026-03-02 10:06:53

RadNet Acquires Gleamer, Making RadNet's DeepHealth the Largest Provider of Radiology Clinical AI Solutions Worldwide
Finviz2026-03-02 10:48:46

AIM ImmunoTech Signs Agreement for Planning of a Proposed Phase 3 Clinical Trial of Ampligen in the Treatment of Late-Stage Pancreatic Cancer
Finviz2026-03-02 14:03:11

Oncolytics Biotech Launches Randomized Colorectal Cancer Study
Finviz2026-03-02 14:06:44
OSTX stock chart
OSTX stock detailsOSTX stock price change
On the last trading day, OSTX stock closed at 1.47 USD, with a price change of 2.80% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more